Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Mol Genet Metab. 2013 Feb 13;109(1):21–27. doi: 10.1016/j.ymgme.2013.02.002

Figure 1.

Figure 1

Characterization of wild type (WT) and patient fibroblast samples for VLCAD activity and antigen. The top line shows mutations identified in patient cell lines. Western blot results using VLCAD antisera are shown in the next line. The bottom line gives the VLCAD activity from fibroblast extracts presented as a percentage of the concurrent wild type control (ND is non-detectable). All samples were also tested for MCAD activity and antigen as a control and gave normal levels of both (not shown).